Chris Hill
Analyst · Daniel Energy Partners. Please go ahead
Thanks, Larry. Before we review the financial performance for the quarter, the guidance we gave on our last call and past calls, specifically excluded the impact of any FX gains or losses and assumed an effective tax rate of 20%. So accordingly, our discussion today, excludes any foreign exchange gain or loss for current and prior periods. During the third quarter of 2024, the company recorded an adjustment of $1.4 million to stock compensation expense for certain performance share awards which are no longer expected to vest. The comparison periods for the second quarter of 2024 and third quarter of 2023 also include items that were discussed in those calls and highlighted in our earnings release for those periods. These items have also been excluded from our discussion of the financial results today. You can find a summary of those items in the tables attached to our press release for the third quarter of 2024. So now looking at the income statement. Revenue $134.4 million in the third quarter, an increase of 3% from $130.6 million in the prior quarter and up over 7% from $125.3 million in the prior year’s third quarter. The revenue growth, both sequentially and year-over-year is associated with increased demand and certain international regions for Reservoir Rock and Fluid analytical programs, as well as a higher level of both product shipments into international markets. These increases were partially offset by delayed projects caused by the storms in the Gulf of Mexico and a lower level of completion product sales in the US land markets. Of this revenue, service revenue, which is more international was $98.8 million for the quarter, up 3% sequentially and up over 6% from last year. Demand for our laboratory-based Reservoir Rock and fluid analytical programs continues to improve and is expected to continue growing globally with stronger growth in certain international regions. However, this sequential growth was offset by delays in well completion diagnostic projects caused by the multiple storms in the Gulf of Mexico. Product sales, which are more equally tied to North America and international activity were $35.6 million for the quarter, up 4% sequentially and up 10% from last year. Sequentially, international product sales increased 24%. However, the growth in international sales this quarter was partially offset by a lower level of product sales into the US land market. Our international product sales are typically larger bulk orders, and can vary from one quarter to another Moving on to cost of services ex items for the quarter were approximately 76% of revenue, improved from 78% in the prior quarter and up from 74% last year. Sequential improvement was primarily due to the improved utilization of our global laboratory network with a higher revenue base since likely different mix of services. As we discussed previously, in February, a fire damaged a portion of one building on our campus of our VET Advanced Technology Center in Aberdeen. Although our insurance programs are reimbursing us for operating costs and additional costs associated with the remediation of the equipment in the facility, the associated insurance proceeds are recorded as other income and not reflected in cost of services or revenue. Cost of sales ex items in the third quarter was 88% of revenue, which increased from 82% last quarter and 85% from last year. The sequential change was primarily due to a lower level of product sales in the US market, which contributed to a decrease in manufacturing efficiencies and absorption of fixed cost. Onshore completion activity in the US is expected to decrease in the fourth quarter, but rebound and improve in the first quarter of 2025. The company will continue to manage the business as efficiently as possible through this volatility in the US market. G&A ex items for the quarter was $10 million, a slight decrease from prior quarter, which was $10.3 million. As discussed in our previous call, the G&A expense in 2024 includes cost associated with a couple of projects initiated during the year. One, in implementing a global human Capital management system and two, a third-party assessment of our cyber security environment. For 2024, we expect G&A, ex items to be approximately $39 million to $41 million. It is also important to note that a 100% of our corporate G&A expenses are allocated and absorbed into the financial performance of the reported segments. Depreciation and amortization for the quarter was $3.7 million, relatively flat compared to last quarter. EBIT ex items for the quarter was $18.2 million, an increase of 11% from $16.4 million last quarter, which improved our EBIT margin by a 100 basis to approximately 14%. EBIT margins are up from 13% last quarter and year-over-year. Our operating income for the quarter on a GAAP basis was $19.8 million. Interest expense of $3.1 million decreased slightly from $3.2 million last quarter. The decrease was primarily due to lower average borrowings on the credit facility this quarter. Income tax expense, an effective rate of 20% and ex items was $3 million for the quarter. On a GAAP basis, we recorded a tax expense of $4.7 million for the quarter. The effective tax rate will continue to be sublet sensitive to the geographic mix of earnings across the globe and the impact of items discrete to each quarter. Additionally, the company continues to evaluate and finalize tax planning associated with the new tax structure after redomesticating the parent company from The Netherlands to the US. We continue to project the company’s effective tax rate to be approximately 20%. Net income ex items for the quarter was $11.8 million, an increase of 14% from $10.4 million last quarter and up from $10.3 million in the third quarter of last year. On a GAAP basis, we recorded net income of $11.7 million for the quarter. Earnings per diluted share ex items was $0.25 for the quarter, up from $0.22 last quarter and the third quarter of last year. On a GAAP basis, earnings per diluted share were also $0.25 for the quarter. Turning to the balance sheet. Receivables were $117.6 million, up slightly from $115.6 million last quarter end. Our DSOs for the third quarter were at 74 days, which improved slightly from 75 days last quarter. We anticipate that our DSO will continue to improve and in future quarters. Inventory at September 30th 2024 was $65.5 million, down approximately $4.4 million from last quarter end, and down $9.6 million from when our inventory peaked in the third quarter last year. Inventory turns for the quarter were 1.9 and have continued to improve over the last few quarters. We continue to focus our efforts on reducing the amount of inventory we are currently carrying and anticipate inventory turns will get gradually improved and inventory levels to decline as we progress through the remainder of 2024 and into 2025. And now on the liability side of the balance sheet, our long-term debt was $142 million at the end of the third quarter of 2024 and considering cash of $21.5 million, net debt was $120.5 million, which decreased $11.8 million or 9% from last quarter. For 2024, net debt has decreased by $30.4 million or 20% from the end of last year. Free cash flow generated during the quarter was primarily used to reduce debt. Our leverage ratio was reduced to 1.47 at September 30th from 1.66 last quarter end. As mentioned by Larry, this quarter marks, the lowest leverage ratio that the company has achieved in over six years. Our debt is currently comprised of our senior notes at $110 million, and $32 million outstanding under our bank credit facility. Our credit facility has a borrowing capacity of $135 million, of which $92 million was still available as of September 30, 2024. The company will remain focused on executing its strategic business initiatives, while continuing to apply free cash towards reducing debt and the leverage ratio. Looking at cash flow, for the third quarter of 2024, cash flow from operating activities was $13.1 million and after paying $2.7 million of CapEx, our free cash flow for the quarter was $10.4 million. The company generated free cash flow of $27.1 million for the first nine months of the year, a significant improvement from the same period last year. As we indicated in our last call, we expect CapEx to modestly Expand in 2024, compared to 2023 and we will continue to manage investment in working capital during a period of growth. Additionally, we expect CapEx to remain aligned with activity levels and for the full year 2024, we expect capital expenditures to be in the range of $12 million to $13 million. Core will continue its strict capital discipline and asset-light business model with capital expenditure, primarily targeted at growth opportunities. Core Lab’s global laboratory networks and intellectual property continues to provide operational leverage and the ability to grow revenue and profitability with minimal capital requirements. Additionally, we continue to improve the efficiencies in our global laboratory infrastructure through some consolidation of facilities and investments in automation. Capital expenditures have historically ranged from 2.5% to 4% of revenue even during periods of significant growth. We believe evaluating a company's ability to generate free cash flow and free cash flow yield is an important metric for shareholders when comparing and projecting company’s financial results, particularly for those shareholders who utilize discounted cash flow models to assess valuations, I will now turn it over to Gwen for an update on our guidance and outlook.